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Megakaryocytic differentiationEndocytosis is pivotal for uptake of ﬁbrinogen from plasma into megakaryocytes and platelet α-granules. Due
to the complex adaptor and cargo contents in endocytic vehicles, the underlying mechanism of ﬁbrinogen
uptake is not yet completely elucidated. In this study, we investigated whether the endocytic adaptor protein
Disabled-2 (DAB2) mediates ﬁbrinogen uptake in an adaptor-speciﬁc manner. By employing primary mega-
karyocytes and megakaryocytic differentiating human leukemic K562 cells as the study models, we found
that ﬁbrinogen uptake is associated with the expression of integrin αIIbβ3 and DAB2 and is mediated
through clathrin-dependent manner. Accordingly, constitutive and inducible knockdown of DAB2 by small
interfering RNA reduced ﬁbrinogen uptake for 53.2±9.8% and 59.0±10.7%, respectively. Culturing the
cells in hypertonic solution or in the presence of clathrin inhibitor chlorpromazine abrogated clathrin-
dependent endocytosis and diminished the uptake of ﬁbrinogen. Consistent with these ﬁndings, 72.2±
0.2% of cellular DAB2 was colocalized with clathrin, whereas 56.4±4.1% and 54.6±2.0% of the internalized
ﬁbrinogen were colocalized with clathrin and DAB2, respectively. To delineate whether DAB2 mediates ﬁ-
brinogen uptake in an adaptor-speciﬁc manner, K562 stable cell lines with knockdown of the adaptor
protein-2 (AP-2) or double knockdown of AP-2/DAB2 were established. The AP-2 knockdown cells elicited
normal ﬁbrinogen uptake activity but the uptake of collagen was diminished. In addition, collagen uptake
was further reduced in DAB2/AP-2 knockdown cells. These ﬁndings thereby deﬁne an adaptor-speciﬁc
mechanism in the control of ﬁbrinogen uptake and implicate that DAB2 is the key adaptor in the clathrin-
associated endocytic complexes to mediate ﬁbrinogen internalization.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Fibrinogen is a well-known plasma and platelet α-granule protein
that mediates platelet aggregation and ﬁbrin clot formation during
vessel wall injury [1,2]. Upon megakaryocytic differentiation and
platelet biogenesis, integrin αIIbβ3 (GPIIb-IIIa) plays a key role in
the uptake and storage of plasma ﬁbrinogen in plateletα-granule. Ac-
cordingly, the antagonists of integrin αIIbβ3 inhibit ﬁbrinogenlipoprotein E receptor 2; ARH,
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l rights reserved.endocytosis in guinea pig megakaryocytes and platelets [3,4].
Thrombasthenia with functional loss of platelet integrin αIIbβ3 also
results in ﬁbrinogen deﬁciency in platelets and causes irregular
bleeding [5,6]. Despite the fact that integrin αIIbβ3-mediated ﬁbrino-
gen endocytosis is important for maintaining platelet function and
homeostasis, the underlying mechanism for the uptake of ﬁbrinogen
during thrombopoiesis is not yet completely understood.
Endocytosis involves the clustering of cell-surface molecules into
regions of plasma membrane known as coated pits. Both clathrin-
dependent and -independent pathways have been implicated in
sorting and targeting trafﬁcking vesicles to different compartments
for storage, degradation and recycling [7,8]. In clathrin-coated vesi-
cles, different internalization signals and cargo contents have been
reported to mediate endocytosis of the receptors and their bound li-
gands [8]. The best understood internalization signal employs the
binding of tyrosine-based YXXØ sequence to the μ2 subunit of the
adaptor protein-2 (AP-2) adaptor heterotetramer, where Ø repre-
sents a residue with a bulky hydrophobic side chain [9,10]. Transfer-
rin receptor (TR) is one of the classical receptors that utilize the YXXØ
sequence to associate with clathrin-coated vesicles for internalization
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mediated endocytosis are affected by diminishing AP-2 expression,
indicating that other adaptors can operate clathrin-dependent endo-
cytosis in the absence of AP-2 [12,13]. For example, the G protein-
coupled receptors employ an alternate system centered around β-
arrestin [14], while the low density lipoprotein receptor (LDLR), low
density lipoprotein receptor-related protein 1 (LRP1), and integrin
β1 use the NPXY internalization motif to interact with the adaptor
proteins such as Disabled-2 (DAB2), autosomal recessive hypercho-
lesterolemia (ARH), and Numb [15]. Hence, endocytosis of surface re-
ceptors and their bound ligands by clathrin-dependent pathways is
highly heterogeneous and dynamic.
Two NPXY/NPXY-like motifs are present in the integrin β3 cyto-
plasmic tail that interacts with numerous cellular proteins including
talin, Dok1/2, Syk, myosin, Shc and DAB2 and functionally links with
receptor activation, signaling and internalization [16–23]. Among
the integrin αIIbβ3-associated proteins, DAB2 is up-regulated during
megakaryocytic differentiation and is abundantly expressed in
human platelet α-granules [19,24–28]. Recent study further unveils
that DAB2 is required for mesoderm differentiation of murine embry-
onic stem cells [29]. Moreover, DAB2 is a negative regulator of
integrin αIIbβ3-mediated ﬁbrinogen adhesion and cell signaling and
is secreted to display on platelet surface in both sulfatide- and
integrin αIIb-bound states to control the extent of clotting response
upon platelet activation [19,27,28]. In addition to playing a role in
cell signaling [30–34], DAB2 is an NPXY sequence-speciﬁc adaptor
protein that regulates clathrin-coated vesicles trafﬁcking involving
binding with myosin VI [35,36] and receptor recycling of LDLR [37],
apolipoprotein E receptor 2 (ApoER2) [38], LRP1 [39], megalin [40],
intrinsic factor-vitamin B12 receptor cubam [41], integrin β1
[42–44], and type II transforming growth factor-beta receptor [45].
This task is mainly mediated by engaging the N-terminal phos-
photyrosine binding (PTB) domain of DAB2 with the NPXY motif of
the receptor [18,19]. While the involvement of DAB2 in integrin
αIIbβ3-mediated ﬁbrinogen adhesion and cell signaling provides ev-
idence that the interaction between DAB2 and integrin αIIbβ3 is of
signiﬁcance in platelet function, whether or not DAB2 has a role in
receptor-mediated ﬁbrinogen endocytosis remains to be elucidated.
In this study, we used both murine primary megakaryocyte and
human leukemic K562 cells to address the underlying mechanism of
ﬁbrinogen endocytosis, in particular the role of DAB2 in the uptake
of ﬁbrinogen. We report herein that both integrin αIIbβ3 activation
and DAB2 expression are required for clathrin-dependent ﬁbrinogen
uptake in megakaryocytic differentiating cells. This study thereby
highlights a novel DAB2 function and sheds new insight for the mo-
lecular mechanism of ﬁbrinogen uptake during megakaryocytic
maturation.
2. Materials and methods
2.1. Materials
Fetal bovine serum (FBS), penicillin, streptomycin, trypsin,
GENETICIN (G418), OPTI-MEM, Roswell Park Memorial Institute
(RPMI) 1640 medium, Dulbecco's Modiﬁed Eagle's Medium (DMEM),
Lipofectamine 2000 (LF2000) reagent, Gateway LR Clonase II Enzyme
mix, Alexa Fluor 546-conjugated goat anti-rabbit IgG, Alexa Fluor 488-
conjugated donkey anti-mouse IgG, Alexa Fluor 488-conjugated and
Alexa Fluor 546-conjugated human ﬁbrinogen were purchased from
Invitrogen (Carlsbad, CA). The horseradish peroxidase (HRP)-conjugated
goat anti-rabbit IgG, the clathrin inhibitor chlorpromazine (CPZ) and
the collagen type I from bovine skin were purchased from SIGMA
(Saint Louis, MO). Anti-integrin αIIb and anti-integrin β3 (for Western
blot) antibodies were purchased from Santa Cruz Biotechnologies
(Santa Cruz, CA). The anti-CD61 antibody (forﬂow cytometry)was pur-
chased from Serotec (Serotec, Kidlington, Oxford, UK). The HRP-conjugated goat anti-mouse IgG and the chemiluminescentHRP substrate
were purchased from Millipore (Billerica, MA). The anti-DAB2, anti-
adaptin-α (AP-2) and anti-caveolin 1 antibodies were purchased from
BD Biosciences (Franklin Lakes, NJ). The anti-clathrin heavy chain anti-
body was purchased from Abcam (Cambridge, MA). Lentivirus-based
AP-2 shRNA expression plasmid was provided by the National RNAi
Core Facility, Academia Sinica, Taiwan (Taipei, Taiwan). The kistrin
(IPRGDMP) and RGDS peptides were synthesized by MDBio, Inc. (Taipei,
Taiwan).
2.2. Plasmids
The doxycyclin (Dox)-inducible pHUSH cloning vector and the
pShuttle-H1-shRNA-2x-TetO2 vector [46] were a gift from Dr. David P.
Davis (Genetech, South San Francisco, CA). For construction of
pHUSH-shDAB2-1605, the following sense and antisense complemen-
tary DNA oligonucleotides were annealed: sense (5′-GATCCCCG
AGGCAGAAGGACTGCTAATTCAAGAGATTAGCAGTCCTTCTGCCTCTTTTT-
TA-3′) and antisense (5′-AGCTTAAAAAAGAGGCAGAAGGACTGCTAAT-
CTCTTGAATTAGCAGTCCTTCTGCCTCGGG-3′). The annealing products
were ligated to the Bgl II and Hind III-digested pShuttle-H1-shRNA-2x-
TetO2 and were subcloned into the pHUSH vector using Gateway LR
Clonase II Enzyme mix. The human integrin αIIb expression plasmid
was a gift from Dr. Mark H. Ginsberg (University of California, San
Diego, CA). The human integrin β3 expression plasmid was a gift from
Dr. Erkki Ruoslahti (University of California, Santa Barbara, CA). The ex-
pression plasmid for p82-S24A has been described previously [31].
2.3. Megakaryocytic differentiation and ﬁbrinogen uptake assay
The animal work has been reviewed and approved by the Institu-
tional Animal Care and Use Committee of Chang Gung University (Ap-
proval ID: CGU09-113) and was conducted according to the guideline
as shown in the “Guide for Laboratory Animal Facilities and Care” as
promulgated by the Council of Agriculture, Executive Yuan, Republic
of China. For ex vivo primary megakaryocyte differentiation, CATCH
buffer (1× phosphate-buffered saline (PBS) containing 0.38% sodium
citrate, 1 mM adenosine and 2 mM theophylline) was used to ﬂush
out murine bone marrow cells from the femurs and tibias of C57BL/
6 mice (male, 6–8 week-old). After incubation with RBC lysis buffer
(150 mM NH4Cl, 10 mM NaHCO3, 0.1 mM EDTA) at 4 °C for 10 min,
cells were pelleted by centrifugation at 1500 rpm for 5 min and
resuspended in the culture medium (OPTI-MEM supplemented with
10% FBS, 100 U/ml penicillin and 100 μg/ml streptomycin) containing
10 ng/ml thrombopoietin (TPO). At day 5 after differentiation induc-
tion, the large-size megakaryocytes were isolated by a modiﬁed bo-
vine serum albumin (BSA) density gradient (0/1.5/3/4.5%) [47]. For
megakaryocytic differentiation of K562 cells, the cells (5×105/
10 cm dish) were treated with 10 ng/ml of TPA for 48 h andwere sub-
jected to molecular and phenotypic analysis.
For ﬁbrinogen uptake, the cells were washed with OPTI-MEM and
incubated with 0.5 μM ﬂuorescence-conjugated human ﬁbrinogen for
the indicated time. After several washes with CATCH buffer, the cells
were analyzed by ﬂuorescence microscopy (Zeiss 200M), confocal
microscopy (Zeiss LSM 510) and ﬂow cytometry (FACScan). The rela-
tive ﬂuorescence intensity was quantiﬁed using the ImageJ software
(National Institute of Health).
2.4. Cell culture and transient transfection
The K562 cells [25,26] were cultured in RPMI 1640 medium sup-
plemented with 5% FBS, 100 U/ml penicillin and 100 μg/ml strepto-
mycin. The CHO-K1 cells were cultured in DMEM supplemented
with 10% FBS, 100 U/ml penicillin and 100 μg/ml streptomycin. For
transient transfection, the K562 (2×106/well) and CHO-K1 (106/
well) cells in the 6-well plate were transfected with 6 μg DNA
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fected CHO-K1 cells (106/well) in the 6-well plate were treated with
10 mM DTT at 37 °C for 30 min.
2.5. Generation of shDAB2 and shAP-2 stable cell lines
The shDAB2 stable cell lines V7 and si8 were established and
maintained in RPMI 1640 medium supplemented with 300 μg/ml G418
as described previously [19]. To establish the doxycyclin-inducible
shDAB2 stable cell line, the K562 cells were transfectedwith pHUSH vec-
tor or pHUSH-shDAB2-1605. At 48 h after transfection, the cells were di-
luted to 1 cell/96-well with RPMI 1640 and were selected with 1 μg/ml
puromycin for 2–3 weeks. After selection, the cells were maintained in
RPMI 1640 with 0.7 μg/ml puromycin.
To establish shAP-2 or the control shLuc stable K562 cell lines, len-
tiviruses encoding shAP-2 or shLuc were produced using 293T cells as
described in the protocol provided by the National RNAi Core Facility,
Academia Sinica, Taiwan. Brieﬂy, the 293T packaging cells wereFig. 1. Integrin αIIbβ3 expression and activation are required for ﬁbrinogen uptake into mu
Murine bone marrow precursor cells were isolated and cultured as described in the Material
non-megakaryocytic small cells (NC) were separated and enriched by the BSA density grad
1 h and were observed by ﬂuorescence and phase contrast microscopy at a 400×magniﬁcati
megakaryocytes. The primary MK and NC cells were incubated with RGDS or kistrin peptide
in panel A. The ﬁbrinogen uptake for individual megakaryocyte (n=50 in each experiment
tensity for each assay condition. The data represent the mean±SEM of 3 independent exp
αIIbβ3 expression and activation are required for ﬁbrinogen internalization. The CHO-K1 ce
αIIb/β3 (CHO-αIIbβ3) expressing plasmids for 24 h followed by treatment with 10 mM DT
ﬂow cytometric analysis using the anti-CD61 and anti-αIIbβ3 (10E5) antibodies, respectivel
dent experiments (panel C). The DTT-treated CHO-vector and CHO-αIIbβ3 cells were subje
quantiﬁed by ﬂow cytometry and a representative histogram was presented. Fibrinogen up
pendent experiments (panel D). *pb0.05 and **pb0.01 when compared with the vector-tracotransfected with pMD.G, pCMVΔR8.91, and the pLKO.1-shLuc or
pLKO.1-shAP2 plasmids by LF2000. Viral particles were harvested to
infect V7 and si8 in the presence of 8 μg/ml protamine sulfate. At
24 h post-infection, the cells were washed and were selected with
1.5 μg/ml puromycin for 2 weeks. The stable clones were maintained
in RPMI 1640 supplemented with 1.5 μg/ml puromycin and 300 μg/ml
G418.
2.6. Preparation of cell extracts and Western blot analysis
Cells were washed twice with cold 1× PBS, lysed in the lysis buffer
(50 mM HEPES, pH 7.5, 150 mM NaCl, 10% glycerol, 1% Triton X-100,
1.5 mM MgCl2, 10 μg/ml aprotinin, 10 μg/ml leupeptin, 1 mM
phenylmethylsulfonyl ﬂuoride, 200 μM sodium orthovanadate,
10 mM sodium ﬂuoride and 100 μM EGTA) and kept on ice for
30 min [30]. After centrifugation at 10,000 rpm for 10 min, the super-
natants were collected as the total cell lysates. Fifteen micrograms of
proteins was subjected to a denaturating 10% SDS-polyacrylamiderine primary megakaryocytes. (A) Fibrinogen endocytosis in primary megakaryocytes.
s and methods. At day 5 after TPO (10 ng/ml) treatment, megakaryocytes (MK) and the
ient. The cells were incubated with Alexa Fluor 546-conjugated ﬁbrinogen (0.5 μM) for
on. Length of bar=100 μm. (B) RGDS and kistrin peptides inhibit ﬁbrinogen uptake into
s (100 μM) for 30 min and ﬁbrinogen internalization assay was performed as described
) was quantiﬁed by ImageJ software and was expressed as the relative ﬂuorescence in-
eriments. **pb0.01 when compared with the untreated MK cells. (C–D) Both integrin
lls (106/well) in the 6-well plate were transfected with vector (CHO-vector) or integrin
T for 30 min at 37 °C. The CHO-αIIbβ3 cells without DTT treatment were subjected to
y. A representative histogramwas presented with similar results obtained in 2 indepen-
ct to ﬁbrinogen internalization assay for 3 or 6 h. The amount of ﬁbrinogen uptake was
take was expressed as relative MFI with the data represent the mean±SEM of 3 inde-
nsfected CHO-K1 cells.
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transferring to a PVDF membrane, the membrane was blocked by 5%
nonfat dry milk in 1× PBS containing 0.1% Tween 20 (PBST). Then, the
PVDF membrane was hybridized with the primary antibody for 1.5 h,
and washed three times in PBST for 10 min. The appropriate HRP-
conjugated secondary antibody was incubated for another 1 h.
Following washes in PBST, the expression of protein was detected by
the chemiluminescent HRP substrate as described by themanufacturer.
2.7. Blockage of clathrin-mediated endocytosis by hypertonic solution
and clathrin inhibitor
For blocking clathrin-mediated endocytosis, the cells were washed
with OPTI-MEM and cultured in hypertonic solution (0.45 M sucrose)
for 30 min or in the presence of 20 μM CPZ for 2 h. Then 0.5 μM
ﬂuorescence-conjugated human ﬁbrinogen was added into the medi-
um for ﬁbrinogen internalization followed by microscopy or ﬂow
cytometric analysis.
2.8. Immunoﬂuorescent staining
The cells were cytospun on coverslips, ﬁxed with 4% paraformal-
dehyde at room temperature for 30 min and permeabilized by
0.075% Triton X-100 at room temperature for 10 min. The ﬁxed cells
were blocked with 3% BSA and incubated with appropriate dilution
of primary antibody (1:50 for DAB2, 1:50 for AP-2, and 1:300 for
clathrin) at room temperature for 1 h. The cells were then washed
with CATCH buffer and incubated with Alexa Fluor 488-conjugated
goat anti-mouse (for DAB2 and AP-2) or Alexa Fluor 546-conjugated
goat anti-rabbit (for clathrin) secondary antibodies (1:200) at room
temperature for 40 min. After counterstaining with 4′,6-diamidino-
2-phenylindole (DAPI), the cells were mounted and ready for obser-
vation by confocal microscopy. As a negative control, cells were incu-
bated with the control IgG antibody upon which no signal was
detected. The images were analyzed with Zeiss LSM Image Browser
Version (Zeiss) for determining the colocalization coefﬁcient between
the indicated proteins. The ﬂuorescent images of the intact cells with-
out any overlapping were taken and the colocalization was deﬁned as
those areas where the ﬂuorescent peaks of the two ﬂuorescent dyes
overlay and were above background. The colocalization coefﬁcient
was deﬁned as the sum of intensities of colocalization pixels in the
two channels above the overall sum of pixel intensities above the
threshold in each channel which is determined automatically by
Zeiss LSM Image Browser Version software.Fig. 2. Megakaryocytic differentiating K562 cells as a cell study model for ﬁbrinogen uptake
kemic K562 cells (5×105/10 cm dish) were treated with 10 ng/ml TPA (T) or vehicle contro
(0.5 μM) for 16 h. The ﬁbrinogen uptake was observed by ﬂuorescence and phase contrast m
ternalization of megakaryocytic differentiating K562 cells. The K562 cells (5×105/10 cm di
cubated with RGDS or kistrin peptides (100 μM) for 30 min before ﬁbrinogen internalizatio
expressed as the relative MFI. The data represent the mean±SEM of 3 independent experi2.9. Flow cytometry analysis
The cells were washed twice and incubated with anti-CD61 anti-
body (1:500) at 4 °C for 1 h, followed by incubation with Alexa
Fluor 488-conjugated goat anti-mouse (1:50) secondary antibody at
room temperature for 40 min. Then, cells were washed and analyzed
by ﬂow cytometry using CellQuest software (BD Biosciences). The
mean ﬂuorescence index (MFI) was deﬁned as the product of percent
positive cell and the mean cell ﬂuorescence of the positive population
[48].
2.10. Statistical analysis
Student's t-test was used for statistical analysis. A pb0.05 was
considered as statistically signiﬁcant.
3. Results
3.1. Integrin αIIbβ3 expression and activation are required for ﬁbrinogen
uptake into murine primary megakaryocytes
Fibrinogen uptake has been demonstrated in guinea pig megakar-
yocytes in vivo [3,4]. To determine whether ﬁbrinogen is internalized
by the primary megakaryocytes obtained from ex vivo differentiation
of murine bone marrow cells, Alexa Fluor 546-conjugated ﬁbrinogen
was incubated with the enriched megakaryocytes and ﬁbrinogen up-
take was visualized by confocal microscopy (Fig. 1A). Our data re-
vealed that ﬁbrinogen was internalized by primary megakaryocytes
but not the non-megakaryocytic small cells obtained from the top-
layer of BSA density gradient during enrichment of megakaryocytes.
Quantitative analysis revealed that ﬁbrinogen uptake by primary
megakaryocytes was ~700-fold higher when compared with the
non-megakaryocytic small cells; the relative ﬂuorescence intensity
is 100% versus 0.14±0.1% (Fig. 1B).
The RGD sequences are involved in the interaction between
integrin αIIbβ3 and ﬁbrinogen [49]. Accordingly, RGD-containing
synthetic peptides have been shown to block αIIbβ3 function [50].
To assure ﬁbrinogen uptake is mediated by integrinαIIbβ3 in primary
megakaryocytes, we pretreated bone marrow-derived megakaryo-
cytes with the synthetic RGDS or kistrin peptides that are based on
the amino acid sequences from the RGD domain of ﬁbrinogen γ-
chain or the viper venom disintegrin kistrin, respectively [3,51].
Fibrinogen uptake assay revealed that both RGDS and kistrin peptides
decreased the levels of ﬁbrinogen internalization to 49.5±0.2% and. (A) Fibrinogen uptake by megakaryocytic differentiating K562 cells. The human leu-
l ethanol (E) for 48 h and then incubated with Alexa Fluor 488-conjugated ﬁbrinogen
icroscopy. Length of bar=40 μm. (B) RGDS and kistrin peptides inhibit ﬁbrinogen in-
sh) were treated with 10 ng/ml TPA (T) or vehicle control ethanol (E) for 48 h and in-
n assay. The amount of ﬁbrinogen uptake was quantiﬁed by ﬂow cytometry and was
ments. **pb0.01 when compared with TPA-treated K562 cells.
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These data implicate that ﬁbrinogen uptake into murine primary
megakaryocytes is through integrin αIIbβ3.
To provide direct evidence for the involvement of integrin αIIbβ3
in ﬁbrinogen uptake, CHO-K1 cells were transfected with integrin
αIIb and β3 expression plasmids (CHO-αIIbβ3) and were subjected
to ﬁbrinogen uptake assay. Western blot and ﬂow cytometric analy-
ses revealed that CHO-αIIbβ3 but not the vector control (CHO-
vector) cells expressed integrin αIIb and β3 protein (Supplementary
Fig. S1) and the surface integrin αIIbβ3 complex (Fig. 1C). However,
ﬁbrinogen uptake was not observed for both CHO-αIIbβ3 and CHO-
vector (data not shown), indicating that expression of integrin
αIIbβ3 alone is not sufﬁcient for cellular uptake of ﬁbrinogen. Upon
activation of αIIbβ3 by dithiothreitol (DTT) [52], ﬁbrinogen internal-
ized by CHO-αIIbβ3 at 3 and 6 h was 40.9±6.7 and 72.0±22.3 fold of
CHO-vector at 3 h after the assay, respectively (n=3, Fig. 1D). These
data indicate that αIIbβ3 expression and activation are both required
for ﬁbrinogen uptake.Fig. 3. Expression of shDAB2 inhibits ﬁbrinogen uptake into K562 cells. (A) DAB2 expression
control (V7) or shDAB2 (si8) were treated with 10 ng/ml TPA (T) or vehicle control ethanol (
p96 (DAB2) antibody. The expression of β-actin was used for the control of equal protein lo
for 48 h, the V7 and si8 cells were incubated with Alexa Fluor 546-conjugated ﬁbrinogen (
(panel B). Length of bar=20 μm. The internalized ﬁbrinogen was quantiﬁed by ﬂow cyto
data represent the mean±SEM of 3 independent experiments. (D–E) Conditional knockdow
pressing shDAB2-1605 were cultured in the presence or absence of Dox (1 μg/ml) and we
lysates were subjected to Western blot analysis using anti-p96 (DAB2) antibody (panel A).
internalization assay was performed and the relative MFI for each assay condition was dete
dent experiments. **pb0.01.3.2. TPA-induced megakaryocytic differentiation of K562 cells as a cell
study model to investigate cellular uptake of ﬁbrinogen
DAB2 is up-regulated during megakaryocytic differentiation of
human leukemic K562 cells [24]. To determine whether K562 cells are
capable to internalize ﬁbrinogen and can be used as a cell study
model to investigate DAB2 function in ﬁbrinogen uptake, K562 cells
were treated with 12-O-tetradecanoylphorbol-13-acetate (TPA) to in-
duce megakaryocytic differentiation and were incubated with Alexa
Fluor 488-conjugated ﬁbrinogen. The amount of ﬁbrinogen uptake
was then quantiﬁed by ﬂow cytometry. Our data revealed that ﬁbrino-
gen uptake was barely occurred in the undifferentiated vehicle control
cells (Fig. 2A). In contrast, there was an approximate 23-fold increase
in the uptake of ﬁbrinogen when K562 cells were undergone megakar-
yocytic differentiation. The relative ﬂuorescence intensity was 100% for
TPA-treated cells versus 4.4±1.2% for vehicle control (n=3, pb0.01,
Fig. 2A and B). The uptake of ﬁbrinogen was inhibited by RGDS and
kistrin peptides to 49.8±8.9% and 52.1±7.5% of the control cells,in shDAB2 stable lines. The K562 stable clones (5×105/10 cm dish) expressing vector
E) for 48 h and the total cell lysates were subjected toWestern blot analysis using anti-
ading. (B–C) DAB2 knockdown inhibits ﬁbrinogen internalization. After TPA treatment
0.5 μM) for 16 h and were observed by confocal microscopy at a 1000× magniﬁcation
metry and was expressed as the relative MFI for each assay condition (panel C). The
n of DAB2 inhibits ﬁbrinogen internalization. The stable cells (5×105/10 cm dish) ex-
re treated with 10 ng/ml TPA (T) or vehicle control ethanol (E) for 48 h. The total cell
The expression of β-actin was used for the control of equal protein loading. Fibrinogen
rmined by ﬂow cytometry (panel B). The data represent the mean±SEM of 3 indepen-
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ic differentiating K562 cells are able to internalize ﬁbrinogen through
integrin αIIbβ3-dependent manner and can be used as a cell study
model to reveal DAB2 function in ﬁbrinogen uptake.
3.3. DAB2 is required for ﬁbrinogen uptake into megakaryocytic differen-
tiating cells
DAB2 has been demonstrated as an integrin β3 binding partner by
engaging the NPXY internalization motif of integrin β3 with the PTB
domain of DAB2 [18,19]. The K562 cells that stably expressed vector
control (V7) or shDAB2 (si8) were used in this study to elucidate
whether DAB2 is involved in the regulation of ﬁbrinogen uptake. Con-
sistent with our previous results [19], Western blot analysis revealed
that DAB2 was up-regulated during megakaryocytic differentiation of
V7 whereas the basal and TPA-induced DAB2 was signiﬁcantly re-
duced in si8 (Fig. 3A). Both V7 and si8 were incubated with Alexa
Fluor 546-conjugated ﬁbrinogen to determine whether DAB2 expres-
sion is crucial for ﬁbrinogen uptake. The internalized ﬁbrinogen was
visualized by ﬂuorescence microscopy and was quantiﬁed by ﬂow cy-
tometry. Our data revealed that both V7 and si8 had little ﬁbrinogen
uptake activity in the ethanol vehicle-treated cells (Fig. 3B and C).
Upon TPA treatment, ﬁbrinogen uptake for si8 was reduced signiﬁ-
cantly to 53.2±9.8% of V7 (Fig. 3C, pb0.01).
To rule out the clonal effect associated with the use of a single stable
DAB2 knockdown cell line and to conﬁrm the role of DAB2 in ﬁbrinogen
uptake, we took advantage of the one-vector, Dox-inducible shRNA ex-
pression system [46] to establish inducible DAB2 knockdown K562Fig. 4. Fibrinogen uptake into K562 cells is clathrin-dependent. (A) Expression of clathrin an
with 10 ng/ml TPA (T) or vehicle control ethanol (E) for 48 h. Total cell lysates were subjec
antibodies, respectively. PC3 prostate cancer cell extracts were used as the positive control f
tein loading. (B–C) Hypertonic buffer disrupts ﬁbrinogen uptake of K562 cells. The TPA-trea
sucrose, Hypertonic) for 30 min. Then 0.5 μM Alexa Fluor 546-conjugated ﬁbrinogen was ad
added into the medium for 15 min. All images were optical sections collected from a confo
magniﬁcation (panel B). Length of bar=20 μm. The relative MFI for the internalized ﬂuore
represent the mean±SEM of 5 independent experiments. **pb0.01 when compared with
treated cells were incubated with CPZ (20 μM) for 2 h and ﬁbrinogen internalization assay
tometry. The data represent the mean±SEM of 3 independent experiments. **pb0.01.cells. The inducible shDAB2 (shDAB2-1605) was designed to target
the nucleotide sequences that were different to that for generating
si8. Western blot analysis of the inducible shDAB2 subline conﬁrmed
the knockdown of DAB2 upon Dox treatment (Fig. 3D). With this cell
model system, we found that DAB2 knockdown (+Dox) signiﬁcantly
reduced TPA-induced ﬁbrinogen uptake to 59.0±10.7% of the control
(−Dox) cells (Fig. 3E, pb0.01). These results support the notion that
DAB2 is required for ﬁbrinogen uptake.
To determine whether p82-S24A, the Ser24 phosphorylation site
mutant protein of DAB2, had dominant negative function in ﬁbrino-
gen uptake, K562 cells were transfected with p82-S24A expression
plasmid followed by TPA treatment and ﬁbrinogen uptake assay.
Our data revealed that p82-S24A had no effect on ﬁbrinogen internali-
zation (Supplementary Fig. S2), implicating that Ser24 phosphorylation
of DAB2 may not play a role in this setting.
3.4. Fibrinogen uptake into K562 cells is clathrin-dependent
Fibrinogen has been shown to colocalize with clathrin and the cel-
lular uptake of ﬁbrinogen is a clathrin-dependent process in
megakaryocyte-like, PMA-stimulated CMK cells [48,53]. To determine
whether clathrin contributes to ﬁbrinogen uptake in K562 cells,
Western blot analysis was performed to characterize clathrin expres-
sion in V7 and si8 (Fig. 4A). Our data revealed that clathrin was
expressed in V7 and si8 and was not altered upon TPA-induced mega-
karyocytic differentiation. Furthermore, caveolin, one of the media-
tors of clathrin-independent endocytosis, is not expressed in K562
cells (Fig. 4A).d caveolin in shDAB2 stable lines. The V7 and si8 cells (5×105/10 cm dish) were treated
ted to Western blot analysis using anti-p96 (DAB2), anti-clathrin, and anti-caveolin 1
or caveolin expression. The expression of β-actin was used for the control of equal pro-
ted cells were incubated with normal medium (Normal) or hypertonic buffer (0.45 M
ded into the medium for 1 or 4 h, while the Alexa Fluor 546-conjugated transferrin was
cal microscope (Zeiss LSM 510) or phase contrast ﬂuorescence microscope at a 1000×
scence-conjugated ﬁbrinogen was determined by ﬂow cytometry (panel C). The data
TPA-treated V7 or si8 cells under normal medium condition. (D) The ethanol or TPA-
was performed. The relative MFI for each assay condition was determined by ﬂow cy-
Fig. 5. Colocalization of the internalized ﬁbrinogen, DAB2 and clathrin in megakaryocytic differentiating cells. (A) Internalized ﬁbrinogen colocalizes with clathrin. The TPA-treated
cells were incubated with Alexa Fluor 488-conjugated ﬁbrinogen for 2 h, and the cells were stained with anti-clathrin antibody followed by the Alexa Fluor 546-conjugated goat-
anti-rabbit secondary antibody. (B) DAB2 colocalizes with clathrin. The TPA-treated cells were incubated with human ﬁbrinogen (5 μM) for 2 h and the cells were stained with anti-
clathrin and anti-DAB2 antibodies followed by the Alexa Fluor 546-conjugated goat-anti-rabbit (for clathrin) and Alexa Fluor 488-conjuagated goat anti-mouse (for DAB2) secondary
antibodies. (C) Internalized ﬁbrinogen colocalizes with DAB2. The TPA-treated cells were incubated with Alexa Fluor 546-conjugated ﬁbrinogen for 2 h, and the cells were stained
with anti-DAB2 antibody followed by the Alexa Fluor 488-conjuagated goat anti-mouse secondary antibody. The colocalization coefﬁcients between the indicated proteins were
shown in Table 1. All images were optical sections collected from confocal microscopy analysis. The white boxes indicate the area that was enlarged in the right of the image. Length
of bar=20 μm.
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lution to inhibit both clathrin-dependent and receptor-mediated en-
docytosis followed by internalization assay to investigate whether
ﬁbrinogen uptake is through a clathrin-dependent pathway in K562
cells. In the presence of hypertonic solution, the uptake of ﬁbrinogen
and as a control the uptake of transferrin were both diminished in V7
(Fig. 4B). Fibrinogen uptake was reduced to 26.1±2.7% of the cells in
normal culture medium (n=5, pb0.01, Fig. 4C). The hypertonic solu-
tion did not elicit cytotoxic effect because replating V7 into normal
culture medium resumed the uptake of ﬁbrinogen (data not
shown). Furthermore, the residual activity for ﬁbrinogen uptake in
si8 was decreased further to 20.1±6.9% of the control when cultured
in the hypertonic solution (n=5, pb0.05, Fig. 4B and C). Similar to
these ﬁndings, pretreatment of V7 cells with the clathrin-dependent
endocytic inhibitor CPZ reduced ﬁbrinogen uptake to 61.03% of the
control cells (n=3, pb0.01, Fig. 4D). These results thereby implicate
that both DAB2 expression and clathrin-coated endocytic vehicles
are involved in regulating ﬁbrinogen uptake of K562 cells.
3.5. Colocalization of the internalized ﬁbrinogen with DAB2 and clathrin
To determine whether the internalized ﬁbrinogen forming an
endocytic complex with DAB2 and clathrin in megakaryocytic differen-
tiating cells, the colocalization coefﬁcients between these three mole-
cules were quantiﬁed in V7 and si8 using ﬂuorescent images from
confocal microscopy. Our data revealed that 56.4±4.1% of the internal-
ized ﬁbrinogen colocalized with clathrin in V7 but was barely internal-
ized in si8 (Fig. 5A and Table 1). Furthermore, 54.6±2.0% of the
internalized ﬁbrinogen colocalized with DAB2 and 72.2±0.2% of
DAB2 colocalized with clathrin in V7, respectively (Fig. 5B, C and
Table 1). These data indicate that both DAB2- and clathrin-dependent
endocytic complexes play a role in the uptake of ﬁbrinogen.
3.6. Fibrinogen uptake into megakaryocytic differentiating cells is depen-
dent on DAB2 but not AP-2
In addition to DAB2, AP-2 is one of the major adaptors in clathrin-
coated vehicles. It has been shown that AP-2 coordinates with DAB2
in the regulation of integrin β1 internalization but was not essential
for LDLR endocytosis [37,42,43]. We examined whether DAB2 knock-
down affects the ratio of AP-2-associated clathrin-coated vehicles in
V7 and si8 using the immunoﬂuorescent images from confocal mi-
croscopy. Our data revealed that the colocalization coefﬁcients be-
tween AP-2 and clathrin for V7 and si8 were 41.6±4.2% vs. 53.0±
3.0%, respectively (Fig. 6A and Table 1). TPA-induced megakaryocytic
differentiation of V7 and si8 did not have signiﬁcant effect on the ratio
of AP-2 containing, clathrin-coated vehicles (35.0±2.6% for V7 vs.
35.4±2.2% for si8).
To elucidate whether AP-2 is involved in ﬁbrinogen uptake, V7
and si8 were infected with the lentivirus encoding shAP-2 to generate
AP-2 knockdown or DAB2/AP-2 double knockdown stable cell lines.
Western blot analysis conﬁrmed the knockdown of AP-2 and/orTable 1
Colocalization coefﬁcient of staining proteins in K562 cells.
K562 cells Staining proteins Colocalization coefﬁcienta (%)
V7-TPA Fibrinogen vs. clathrin 56.4±4.1
V7-TPA DAB2 vs. clathrin 72.2±0.2
V7-TPA Fibrinogen vs. DAB2 54.6±2.0
V7-ethanol AP-2 vs. clathrin 41.6±4.2
V7-TPA AP-2 vs. clathrin 35.0±2.6
si8-ethanol AP-2 vs. clathrin 53.0±3.0
si8-TPA AP-2 vs. clathrin 35.4±2.2
a The data represent the mean±SEM of 40 different cell images in 2–3 independent
experiments.DAB2 expression in these cell lines (Fig. 6B, upper panel). Upon TPA
treatment, ﬁbrinogen uptake for the DAB2 and AP-2 knockdown
cells was 39.8±3.5% (pb0.01) and 91.8±12.8% (p>0.5) of vector
control cells, respectively (Fig. 6B, lower panel). Consistent with
these ﬁndings, double knockdown of DAB2 and AP-2 did not elicit
any combined effect on the uptake of ﬁbrinogen. The ﬁbrinogen up-
take for DAB2/AP-2 double knockdown cells reached to 53.7±4.2%
of vector control that was similar to DAB2 knockdown cells. In con-
trast, knockdown of AP-2 or DAB2 alone diminished the uptake of col-
lagen (Fig. 6B, lower panel) and double knockdown of DAB2 and AP-2
elicited combined effect on collagen uptake. These data indicate that
ﬁbrinogen uptake is via a DAB2-dependent but AP-2-independent
pathway, while the uptake of collagen is DAB2- and AP-2-dependent.
4. Discussion
Fibrinogen uptake by megakaryocyte and platelet is crucial for
normal platelet function. In this study, we demonstrate that ﬁbrino-
gen uptake is through a DAB2- but not AP-2-dependent clathrin-
coated vesicles. This study thereby represents the ﬁrst report to iden-
tify DAB2 as an indispensable regulator for the uptake of ﬁbrinogen
during megakaryocytic maturation.
The β3 cytoplasmic tail provides a bridge to link with other cellu-
lar proteins and is involved in the regulation of cell spreading,
integrin activation and ligand internalization. Structural analysis of
the β3 cytoplasmic tail reveals the presence of two NPXY/NPXY-like
motifs at the amino acids 744–747 and 756–759. The NPLY (aa.
744–747) motif is involved in cell spreading [54] and binds Numb,
EPS8, DAB1, Dok-1, and talin [18]. The NITY (aa. 756–759) motif is
crucial for the recruitment of αIIbβ3 to pre-established adhesion
plaques and the internalization of β3 integrin A isoform and
ﬁbrinogen-coated particles [54,55]. Despite it is known that DAB2
binds to the β3-NITY motif through the PTB domain [18], only few
studies address the role of DAB2-integrin β3 binding. Previously, we
demonstrated that DAB2 acts as a negative regulator in the inside-
out signaling of αIIbβ3 through a Ser24 phosphorylation-dependent
manner. Furthermore, down-regulation of DAB2 augments the active
status of integrin αIIbβ3 and increases cell adhesion to immobilized
ﬁbrinogen [19]. Based on the ﬁndings we report in this study, DAB2
can be considered as a key regulator in integrin αIIbβ3-mediated ﬁ-
brinogen uptake that represents a novel functional aspect of DAB2.
These ﬁndings are in accord with the reported function of NITY
motif in the inducible but not the constitutive endocytic activity of
integrin αIIbβ3 [55] and are consistent with DAB2 function as an
NPXY sequence-speciﬁc clathrin adaptor protein in receptor endocy-
tosis, endocytic vehicles trafﬁcking and regulating cell functions
[43,56]. Hence, DAB2 elicits multi-functional activity to the integrin
αIIbβ3 complex highlighting the key role of DAB2 in the regulation
of integrin αIIbβ3.
Different cargo contents have been reported to present in various
clathrin-coated vesicles [8]. According to the data we obtained from
this study, ﬁbrinogen uptake is likely through the DAB2-dependent/
AP-2-independent clathrin-coated vesicles. The AP-2-independent
regulatory scheme has been demonstrated in the endocytosis of
LDLR and EGFR [37,57]. In contrast, the endocytosis of integrin β1
was found to be both DAB2- and AP-2-dependent [42,43] and is in ac-
cord with our ﬁndings that collagen endocytosis is diminished in
DAB2 and DAB2/AP-2 knockdown cells. These results all implicate
the complexity of ligand internalization and cellular trafﬁcking
which suggest the presence of diverse receptor-ligand internalization
pathways that are determined by different cargo-selective adaptors
and trafﬁc vesicles. In megakaryocytes and platelets, multiple sources
of granule protein biogenesis have been reported [48,58–61]. For ex-
ample, endocytosis of plasma-derived factor V by megakaryocytes has
been demonstrated to occur via a clathrin-dependent [48] and LRP-1-
mediated [62] events, while vitronectin is endocytosed via its receptor
Fig. 6. Fibrinogen uptake into K562 cells is DAB2- but not AP-2-dependent. (A) DAB2 knockdown does not affect the colocalization of AP-2 and clathrin. The V7 and si8 cells (5×105/
10 cm dish) were treated with 10 ng/ml TPA (T) or vehicle control ethanol (E) for 48 h. The cells were incubated with human ﬁbrinogen (5 μM) for 2 h and the cells were stained
with anti-clathrin and anti-AP-2 antibodies followed by the Alexa Fluor 546-conjugated goat-anti-rabbit (for clathrin) and Alexa Fluor 488-conjuagated goat anti-mouse (for AP-2)
secondary antibodies. The image was optical sections collected from confocal microscopy analysis. The white boxes indicate areas enlarged in the bottom of the image. The
colocalization coefﬁcients between AP-2 and the internalized ﬁbrinogen for V7 and si8 under the indicated treatment were shown in Table 1. Length of bar=20 μm. (B) DAB2
but not AP-2 knockdown affects ﬁbrinogen uptake. The shDAB2, shAP-2, shDAB2/shAP2 double knockdown and vector control cells (5×105/10 cm dish) were treated with
10 ng/ml TPA (T) or vehicle control ethanol (E) for 48 h. Total cell lysates from the cells under the indicated treatment were subjected to Western blot analysis using anti-p96
(DAB2) and anti-AP-2 antibodies, respectively (upper panel). The expression of β-actin was used for the control of equal protein loading. On the other hand, ﬁbrinogen and collagen
uptake assays were performed and were analyzed by ﬂow cytometry. The relative MFI for the internalized ﬁbrinogen and collagen was determined (lower panel) with the data
representing the mean±SEM of 3 independent experiments. *pb0.05 and **pb0.01 when compared with TPA-treated vector control, shAP-2 or shDAB2 expressing cells.
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tosis and sorting of various platelet granule proteins is worthy to explore
further.The role of AP-2 in clathrin-mediated endocytosis is controversial.
It has been reported that AP-2 is dispensable for the clathrin-dependent
endocytic process. Consistentwith this notion, knockdown of AP-2 does
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al. also reported that silencing of AP-2 subunit selectively depresses
the internalization of TR but not EGFR and LDLR [13]. On the other
hand, AP-2 is essential for clathrin-mediated endocytosis and is indis-
pensable for endocytic coated-pit and coated-vesicle formation [8,63].
In this regard, the surface density of clathrin coats in AP-2-deﬁcient
cells is 12-fold less abundant than in control cells with all of the
remaining coats usually contain a small amount of AP-2 [13]. Boucrot
et al. also reported that clathrin-coated pits are required for LDL inter-
nalization under normal conditionwhile cells can upregulate alternative
endocytic structures to provide compensatory trafﬁcking pathways
under certain conditions of stress [64]. These studies together implicate
that AP-2 is required for optimal coat assembly and trafﬁcking, whereas
alternate monomeric adaptors can sustain endocytic uptake of certain
receptors in the absence of AP-2.
In addition to the clathrin-dependent vesicles, several distinct
endocytic processes can be used for uptake of extracellular cargos
[65]. While ﬁbrinogen uptake still occurs in a small portion of cells
that were treated with hypertonic solution or CPZ, it is likely that
other ﬁbrinogen endocytic mechanisms exist in K562 cells. Several
clathrin-independent pathways including endocytosis via caveolin
or ﬂotillin vesicles, phagocytosis, macropinocytosis, and tran-
sendocytosis have been described as the gateway for different types
of cargoes uptake [65–67]. Because caveolin is not present in the
K562 cells, it is not likely that the residual ﬁbrinogen uptake is medi-
ated through the caveolin-dependent mechanism. Notably, previous
study reported that coverslips coated with RGD-containing peptides
and ﬁbrinogen can induce macropinocytosis in ascidian hyaline
amoebocytes [68]. Whether or not macropinocytosis or other
clathrin-independent pathways are involved in the internalization
of ﬁbrinogen remains to be analyzed.
Howmegakaryocyte and platelet endocytose ﬁbrinogen is compli-
cated by several observations. It has been reported that the αIIbβ3
antagonist does not completely inhibit ﬁbrinogen uptake into the
α-granules of resting platelets and the individuals lacking both αIIbβ3
andαVβ3 are slightly more deﬁcient in ﬁbrinogen [6]. These studies in-
dicate that additionalmolecules are involved in theprocess ofﬁbrinogen
uptake butwith a relativelyminor role. Furthermore, only soluble ﬁbrin-
ogen can bind the activated integrin despite that circulating resting
platelets can internalize ﬁbrinogen [69]. Therefore, it has been hypothe-
sized that ﬁbrinogen may bind to αIIbβ3 by ﬁrst binding to a biological
surface or another integrin (e.g.αVβ3) and act like immobilized ﬁbrino-
gen, allowing for its subsequence uptake and trafﬁcking to the
α-granules by the unactivated αIIbβ3 [4,69]. For primary megakaryo-
cytes, only large-megakaryocytes have been reported to bindﬁbrinogen
while few intermediate-size megakaryocytes and no small αIIbβ3-
expressing progenitors bind ﬁbrinogen in response to agonists [70].
This failure of ﬁbrinogen binding can not be explained by a lack of
αIIbβ3 expression, since the intermediate- and small-size megakaryo-
cytes can bindﬁbrinogen in response toMnCl2. To provide an explanation
for these observations, Shiraga et al. hypothesize that the development of
inside-out signaling is relatively late during megakaryocytic maturation
[70]. With the role of DAB2 in ﬁbrinogen uptake and the up-regulation
of DAB2 during megakaryocytic differentiation, DAB2 may provide a
clue for these seemingly controversial observations. Accordingly, we
found that expression of shDAB2 affects megakaryocytic differentiation
and causes a decrease in ﬁbrinogen uptake of the large-size
megakarycoytes (data not shown). Whether DAB2 expression is linked
to the expression and activation status of integrin αIIbβ3 in primary
megakaryocytes is under investigation in our laboratory.
Because ﬁbrinogen uptake and the subsequent storage in mega-
karyocyte and platelet α-granule are central for normal platelet func-
tions, the ﬁndings we report herein can also explain the signiﬁcance
of DAB2 up-regulation during megakaryocytic differentiation and
the abundant expression of DAB2 in human platelet. Furthermore, it
has been reported that cytoskeleton-dependent internalization ofintegrin αIIbβ3 downregulates activated platelet adhesion in circula-
tion [71]. Hence, the functional signiﬁcance of DAB2 in ﬁbrinogen up-
take may be crucial not only on platelet biogenesis, but also on the
reversible phase of platelet activation. In this regard, DAB2 has
been shown to play a role in the negative regulation of platelet–ﬁ-
brinogen interaction, platelet aggregation and P-selectin-mediated
platelet–leukocyte interactions [27,72]. We therefore postulate that
augmentation of αIIbβ3 internalization could be a key event for DAB2
to elicit its negative regulatory role in platelet aggregation that is
warranted to further investigation.
In conclusion, we present evidence that DAB2 but not AP-2 is re-
quired for integrin αIIbβ3-mediated, clathrin-dependent ﬁbrinogen
uptake in megakaryocytic cells. This study thereby deﬁnes a novel
functional aspect of DAB2 and contributes to our understanding for
the molecular mechanisms of ﬁbrinogen uptake during megakaryo-
cytic maturation.
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